- Home
- APLS vs CPRI Comparison
APLS vs CPRI Comparison
Compare APLS & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLS | CPRI |
|---|---|---|
| Founded | 2009 | 1981 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.2B |
| IPO Year | 2015 | 2011 |
Fundamental Metrics
Financial Performance| Metric | APLS | CPRI |
|---|---|---|
| Price | $17.28 | $18.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | ★ $31.65 | $26.50 |
| AVG Volume (30 Days) | 1.9M | ★ 2.7M |
| Earning Date | 05-06-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | N/A |
| EPS | 0.20 | ★ 1.18 |
| Revenue | $1,003,782,000.00 | ★ $4,442,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.21 | $1.86 |
| P/E Ratio | $86.38 | ★ $15.28 |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $11.86 |
| 52 Week High | $30.48 | $28.27 |
Technical Indicators
Market Signals| Indicator | APLS | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 27.60 | 41.34 |
| Support Level | $17.16 | $16.75 |
| Resistance Level | $20.42 | $18.75 |
| Average True Range (ATR) | 0.71 | 0.83 |
| MACD | -0.15 | 0.13 |
| Stochastic Oscillator | 12.23 | 63.44 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.